AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Bicycle Therapeutics plc

$3.66 -$3.02 (-45.21%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$3.82
Day Range
$3.60$3.80
Year Range
$3.33$8.11
Market Cap
256.17M
AVG Volume
407.87K
Trailing/Forward PE
-1.8/-
PEG ratio
0.04
Dividend Yield
-
Next Earnings Date
2027-03-02
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
025M50M75M100M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BCYC Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q383.53M
26 Q261.2M
26 Q163.5M
25 Q472.59M
25 Q328.34M
25 Q219.28M
25 Q125.72M
24 Q435.27M
24 Q336.9M
24 Q239.57M
Net Income (USD) · TTM
-300M-200M-100M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BCYC Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q3-141.79M
26 Q2-190.41M
26 Q1-219.03M
25 Q4-218.96M
25 Q3-250.66M
25 Q2-242.36M
25 Q1-203.22M
24 Q4-169.03M
24 Q3-166.28M
24 Q2-165.37M
Operating Income (USD) · TTM
-300M-200M-100M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BCYC Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q3-163.11M
26 Q2-210.36M
26 Q1-242.4M
25 Q4-247.01M
25 Q3-290.02M
25 Q2-288.31M
25 Q1-248.36M
24 Q4-209.87M
24 Q3-196.44M
24 Q2-183.4M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: BCYC

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 2 Mar 2027.

Bicycle Therapeutics plc
BCYC
Stockpicker

Video analysis: BCYC

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: BCYC

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.